Noven Therapeutics, LLC, a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2013, the company has rapidly established itself as a leader in the development of innovative transdermal drug delivery systems, focusing primarily on women's health and hormone replacement therapies. With a commitment to enhancing patient care, Noven Therapeutics offers unique products that leverage advanced technology to improve therapeutic outcomes. Their flagship offerings include a range of transdermal patches that provide consistent and effective medication delivery. Recognised for its dedication to quality and innovation, Noven Therapeutics has achieved significant milestones, positioning itself as a trusted name in the healthcare sector. The company continues to expand its operational reach, contributing to advancements in treatment options for patients across the globe.
How does Noven Therapeutics, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Noven Therapeutics, LLC's score of 26 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Noven Therapeutics, LLC, headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or initiatives documented. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. As the industry increasingly focuses on sustainability, Noven's future climate commitments and strategies will be essential for understanding their role in reducing environmental impact.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Noven Therapeutics, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.